TPI to start test runs at JCM manufacturing plant

Note* - All images used are for editorial and illustrative purposes only and may not originate from the original news provider or associated company.

Subscribe

- Never miss a story with notifications

- Gain full access to our premium content

- Browse free from any location or device.

Media Packs

Expand Your Reach With Our Customized Solutions Empowering Your Campaigns To Maximize Your Reach & Drive Real Results!

– Access the Media Pack Now

– Book a Conference Call

– Leave Message for Us to Get Back

Related stories

Autopack to host biggest packaging machinery stand at PPMA Total 2025

Leading independent integrator of packaging lines Autopack will showcase a range...

Bionova Scientific Opens US pDNA Development Facility

The 10,000 ft.² Woodlands site is located near Houston...

The FDA PreCheck Program To Speed-Up US Drug Production

The US Food and Drug Administration announced on August...

Reshoring Amidst Tariff Cloud – Aurobindo Acquires Lannett

Aurobindo acquires Lannett – the US Drugmaker for $250...

China-based drug manufacturer Tianyin Pharmaceutical (TPI) is set to start test run at its 250-ton Jiangchuan Macrolide facility (JCM) for good manufacturing practice (GMP) certification process.
The company will conduct the test runs by the end of this month to investigate whether the plant is maintaining GMP.Additionally, the company will also verify its performance, efficiency, reliability and safety of the Azithromycin API manufacturing at JCM.Following the successful completion of the test runs the company will initiate the GMP certification process.

Latest stories

Related stories

Autopack to host biggest packaging machinery stand at PPMA Total 2025

Leading independent integrator of packaging lines Autopack will showcase a range...

Bionova Scientific Opens US pDNA Development Facility

The 10,000 ft.² Woodlands site is located near Houston...

The FDA PreCheck Program To Speed-Up US Drug Production

The US Food and Drug Administration announced on August...

Reshoring Amidst Tariff Cloud – Aurobindo Acquires Lannett

Aurobindo acquires Lannett – the US Drugmaker for $250...

Subscribe

- Never miss a story with notifications

- Gain full access to our premium content

- Browse free from any location or device.

Media Packs

Expand Your Reach With Our Customized Solutions Empowering Your Campaigns To Maximize Your Reach & Drive Real Results!

– Access the Media Pack Now

– Book a Conference Call

– Leave Message for Us to Get Back